CA
NZ
UK
AU
IND
US
Vaxcyte, Inc. (NASDAQ: PCVX) has recently completed a significant vote among its shareholders, reinforcing the company’s leadership structure and financial oversight. During the meeting held in June 2026, shareholders made several pivotal decisions that reflect a solid level of confidence in the firm.
Travere Therapeutics (NASDAQ: TVTX) is undergoing a leadership transition as part of its efforts to reinforce research and development (R&D) in the pharmaceutical sector. The company recently announced the retirement of a senior research executive, marking a key moment in its organizational evolution. This …
A NASDAQ-listed RNA therapeutics developer (NASDAQ:SLN) secured unanimous shareholder approval for its board, executive compensation, and auditor selection at its annual general meeting.
Obagi, a subsidiary of Waldencast, announced it had received FDA approval for its saypha ChIQ hyaluronic acid injectable.
MiMedx Group (NASDAQ: MDXG) has undertaken substantial legislative changes to its corporate governance framework by amending its bylaws. The new provisions reflect more flexible arrangements for shareholder meetings, which can now be convened through remote communication. This adjustment caters to a growing trend among …
MaxCyte (NASDAQ: MXCT) recently announced it has rectified a compliance issue concerning Nasdaq's minimum bid-price rule, averting a potential delisting scenario.
INVO Fertility, Inc. (NASDAQ: INVO) has recently submitted significant regulatory disclosures aimed at enhancing transparency for investors and stakeholders. The filing primarily features item 7.01, which aligns with Regulation FD, a rule designed to ensure that companies provide equal access to important information for …
DermTech (NASDAQ: DMTK) secured shareholder approval for its board of directors, auditor, and executive compensation plan during its 2026 annual meeting.
Shareholders of Cullinan Therapeutics, Inc. (NASDAQ: CGEM) demonstrated strong support for the company's management and governance framework during a recent voting session. The focus was on key proposals related to corporate governance, resulting in a majority backing for both the reelection of board directors …
Celsion Corporation (NASDAQ: CLSN) has amended its 2018 Stock Incentive Plan to enhance executive accountability and attract top-tier leadership.
Please wait processing your request...